Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REal-world Use of steroidaL mIneralocorticoid reCeptor Antagonists - the RELICS Study - Patient Survey (PS)

NCT05407662 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT05407662
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05407662 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REal-world Use of steroidaL mIneralocorticoid reCeptor Antagonists - the RELICS Study - Patient Survey (PS)
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
November 2, 2022
Completion date
June 13, 2023
Enrollment
600 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease, heart failure, type 2 diabetes mellitus